Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06313359 · ClinicalTrials.gov registry record
Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.
A clinical trial of Peripheral Neuropathy Due to Chemotherapy, sponsored by Texas Woman's University.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06313359: Recruiting study of Peripheral Neuropathy Due to Chemotherapy, sponsored by Texas Woman's University.
NCT06313359 is a study of Peripheral Neuropathy Due to Chemotherapy that is actively recruiting participants, run by Texas Woman's University. The registered enrollment target is 40 participants, below the 54-participant average among 6 other Peripheral Neuropathy Due to Chemotherapy trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06313359, a study of Peripheral Neuropathy Due to Chemotherapy, is actively recruiting participants, sponsored by Texas Woman's University.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.
Primary Outcome
Fall risk will be assessed using the Timed Up and Go (TUG)-Test. For the TUG, the participant will be asked to stand up from a chair, walk 3 m and touch a line on the floor, walk back to the chair and sit down. Timing of the test will begin when the tester gives the command "go" and will be stopped when the participant made contact with the chair as they sat down.
Conditions Studied
Study Locations (1)
Texas
- Texas Woman's University - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-03-30 |
| Est. Completion | 2026-06-30 |
What NCT06313359 shows while recruiting
NCT06313359 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 54-participant average among 6 other Peripheral Neuropathy Due to Chemotherapy trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Peripheral Neuropathy Due to Chemotherapy appearing as the primary indexed condition, and to 0 interventions.
NCT06313359 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06313359 about?
NCT06313359 is a clinical study titled "Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.". The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or mo...
What is the current status of trial NCT06313359?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-03-30. Estimated completion is 2026-06-30.
What conditions does trial NCT06313359 study?
This clinical trial studies the following conditions: Peripheral Neuropathy Due to Chemotherapy.
Who is sponsoring clinical trial NCT06313359?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06313359 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Neuropathy Due to Chemotherapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
RECRUITING · NA
-
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
RECRUITING · NA
-
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
RECRUITING · NA
-
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
RECRUITING · Early Phase 1
-
Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.
RECRUITING · NA
-
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI